These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 36096243)

  • 1. Rhodiola activates macrophage migration inhibitory factor to alleviate non-alcoholic fatty liver disease.
    Liu J; Li D; Dun Y; Li H; Ripley-Gonzalez JW; Zhang J; Qiu L; You B; Liu S
    Life Sci; 2022 Nov; 308():120949. PubMed ID: 36096243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intermittent fasting activates macrophage migration inhibitory factor and alleviates high-fat diet-induced nonalcoholic fatty liver disease.
    Li D; Dun Y; Qi D; Ripley-Gonzalez JW; Dong J; Zhou N; Qiu L; Zhang J; Zeng T; You B; Liu S
    Sci Rep; 2023 Aug; 13(1):13068. PubMed ID: 37567977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Salidroside Attenuates High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease via AMPK-Dependent TXNIP/NLRP3 Pathway.
    Zheng T; Yang X; Li W; Wang Q; Chen L; Wu D; Bian F; Xing S; Jin S
    Oxid Med Cell Longev; 2018; 2018():8597897. PubMed ID: 30140371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 1,2,3,4,6 penta-O-galloyl-β-D-glucose ameliorates high-fat diet-induced nonalcoholic fatty liver disease and maintains the expression of genes involved in lipid homeostasis in mice.
    Kant R; Lu CK; Nguyen HM; Hsiao HH; Chen CJ; Hsiao HP; Lin KJ; Fang CC; Yen CH
    Biomed Pharmacother; 2020 Sep; 129():110348. PubMed ID: 32554245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emodin palliates high-fat diet-induced nonalcoholic fatty liver disease in mice via activating the farnesoid X receptor pathway.
    Shen C; Pan Z; Wu S; Zheng M; Zhong C; Xin X; Lan S; Zhu Z; Liu M; Wu H; Huang Q; Zhang J; Liu Z; Si Y; Tu H; Deng Z; Yu Y; Liu H; Zhong Y; Guo J; Cai J; Xian S
    J Ethnopharmacol; 2021 Oct; 279():114340. PubMed ID: 34171397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exercise inhibits JNK pathway activation and lipotoxicity
    Cui N; Li H; Dun Y; Ripley-Gonzalez JW; You B; Li D; Liu Y; Qiu L; Li C; Liu S
    Front Endocrinol (Lausanne); 2022; 13():961231. PubMed ID: 36147562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Olanzapine causes non-alcoholic fatty liver disease via inhibiting the secretion of apolipoprotein A5.
    Li R; Zhu W; Huang P; Ding C; Tang Y; Lian P; Huang X
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Jun; 47(6):730-738. PubMed ID: 35837772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extracts from Aralia elata (Miq) Seem alleviate hepatosteatosis via improving hepatic insulin sensitivity.
    Hwang KA; Hwang YJ; Kim GR; Choe JS
    BMC Complement Altern Med; 2015 Oct; 15():347. PubMed ID: 26438035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and Mechanism of Polymerized Anthocyanin from Grape-Skin Extract on High-Fat-Diet-Induced Nonalcoholic Fatty Liver Disease.
    Fan M; Choi YJ; Tang Y; Bae SM; Yang HP; Kim EK
    Nutrients; 2019 Oct; 11(11):. PubMed ID: 31717842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sake lees extract improves hepatic lipid accumulation in high fat diet-fed mice.
    Kubo H; Hoshi M; Matsumoto T; Irie M; Oura S; Tsutsumi H; Hata Y; Yamamoto Y; Saito K
    Lipids Health Dis; 2017 Jun; 16(1):106. PubMed ID: 28578672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Salidroside and Curcumin Formula Prevents Liver Injury in Nonalcoholic Fatty Liver Disease in Rats.
    Li HS
    Ann Hepatol; 2018 Aug; 17(5):769-778. PubMed ID: 30145577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atractylenolide III ameliorates Non-Alcoholic Fatty Liver Disease by activating Hepatic Adiponectin Receptor 1-Mediated AMPK Pathway.
    Li Q; Tan JX; He Y; Bai F; Li SW; Hou YW; Ji LS; Gao YT; Zhang X; Zhou ZH; Yu Z; Fang M; Gao YQ; Li M
    Int J Biol Sci; 2022; 18(4):1594-1611. PubMed ID: 35280674
    [No Abstract]   [Full Text] [Related]  

  • 13. Antrodia cinnamomea and its compound dehydroeburicoic acid attenuate nonalcoholic fatty liver disease by upregulating ALDH2 activity.
    Cao YN; Yue SS; Wang AY; Xu L; Hu YT; Qiao X; Wu TY; Ye M; Wu YC; Qi R
    J Ethnopharmacol; 2022 Jun; 292():115146. PubMed ID: 35304272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lycopus lucidus Turcz. ex Benth. Attenuates free fatty acid-induced steatosis in HepG2 cells and non-alcoholic fatty liver disease in high-fat diet-induced obese mice.
    Lee MR; Yang HJ; Park KI; Ma JY
    Phytomedicine; 2019 Mar; 55():14-22. PubMed ID: 30668424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of celastrol on autophagy and endoplasmic reticulum stress-mediated apoptosis in a mouse model of nonalcoholic fatty liver disease].
    Tian T; Liao XC; Zhang M; Wu XM; Guo YT; Tan SY
    Zhonghua Gan Zang Bing Za Zhi; 2022 Jun; 30(6):656-662. PubMed ID: 36038329
    [No Abstract]   [Full Text] [Related]  

  • 16. Lack of ClC-2 Alleviates High Fat Diet-Induced Insulin Resistance and Non-Alcoholic Fatty Liver Disease.
    Fu D; Cui H; Zhang Y
    Cell Physiol Biochem; 2018; 45(6):2187-2198. PubMed ID: 29550812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HCBP6 deficiency exacerbates glucose and lipid metabolism disorders in non-alcoholic fatty liver mice.
    Lu H; Yuan X; Zhang Y; Han M; Liu S; Han K; Liang P; Cheng J
    Biomed Pharmacother; 2020 Sep; 129():110347. PubMed ID: 32535386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Liraglutide protects against nonalcoholic fatty liver disease in ApoE knockout mice with high-fat diet and silenced Acrp30 by increasing AMPK].
    Zhao XY; Zhang LL; Suolang QZ; Yang GY; Li L; Li SB; Chen WW
    Zhonghua Gan Zang Bing Za Zhi; 2014 Nov; 22(11):849-53. PubMed ID: 25531383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Triterpenic acids-enriched fraction from Cyclocarya paliurus attenuates insulin resistance and hepatic steatosis via PI3K/Akt/GSK3β pathway.
    Zheng X; Zhao MG; Jiang CH; Sheng XP; Yang HM; Liu Y; Yao XM; Zhang J; Yin ZQ
    Phytomedicine; 2020 Jan; 66():153130. PubMed ID: 31790897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psoralea corylifolia L. extract ameliorates nonalcoholic fatty liver disease in free-fatty-acid-incubated HEPG2 cells and in high-fat diet-fed mice.
    Hong Y; Choi SI; Hong E; Kim GH
    J Food Sci; 2020 Jul; 85(7):2216-2226. PubMed ID: 32579753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.